248
Views
18
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Expression profiles of adult T-cell leukemia–lymphoma and associations with clinical responses to zidovudine and interferon α

, , , , , , & show all
Pages 1200-1216 | Received 25 Jan 2010, Accepted 23 Feb 2010, Published online: 07 Apr 2010

References

  • Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 2007;7:270–280.
  • Franchini G, Nicot C, Johnson JM. Seizing of T cells by human T-cell leukemia/lymphoma virus type 1. Adv Cancer Res 2003;89:69–132.
  • Mitra-Kaushik S, Harding J, Hess J, Schreiber R, Ratner L. Enhanced tumorigenesis in HTLV-1 tax-transgenic mice deficient in interferon-gamma. Blood 2004;104:3305–3311.
  • Felber BK, Paskalis H, Kleinman-Ewing C, Wong-Staal F, Pavlakis GN. The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. Science 1985;229:675–679.
  • Sodroski JG, Rosen CA, Haseltine WA. Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. Science 1984;225:381–385.
  • Twizere JC, Springael JY, Boxus M, et al Human T-cell leukemia virus type-1 Tax oncoprotein regulates G-protein signaling. Blood 2007;109:1051–1060.
  • Takeda S, Maeda M, Morikawa S, et al Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int J Cancer 2004;109:559–567.
  • Furukawa Y, Kubota R, Tara M, Izumo S, Osame M. Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia. Blood 2001;97:987–993.
  • Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 1991;79:428–437.
  • Waldmann TA, Goldman CK, Bongiovanni KF, et al Therapy of patients with human T-cell lymphotrophic virus I-induced adult T-cell leukemia with anti-Tac, a monoclonal antibody to the receptor for interleukin-2. Blood 1988;72: 1805–1816.
  • Nasr R, Rosenwald A, El-Sabban ME, et al Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells. Blood 2003;101:4576–4582.
  • Ramos JC, Ruiz P Jr, Ratner L, et al IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma. Blood 2007;109:3060–3068.
  • Ishida T, Iida S, Akatsuka Y, et al The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-cell leukemia/lymphoma. Clin Cancer Res 2004;10:7529–7539.
  • Matutes E, Taylor GP, Cavenagh J, et al Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients. Br J Haematol 2001;113:779–784.
  • White JD, Wharfe G, Stewart DM, et al The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia/lymphoma. Leuk Lymphoma 2001;40:287–294.
  • Gill PS, Harrington W Jr, Kaplan MH, et al Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med 1995;332: 1744–1748.
  • Hermine O, Bouscary D, Gessain A, et al Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. N Engl J Med 1995;332:1749–1751.
  • Natkunam Y, Zhao S, Mason DY, et al The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas. Blood 2007;109:1636–1642.
  • Alizadeh AA, Eisen MB, Davis RE, et al Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503–511.
  • Tusher V, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98:5116–5121.
  • Saeed AI, Bhagabati NK, Braisted JC, et al TM4 microarray software suite. Methods Enzymol 2006;411:134–193.
  • Subramanian A, Tamayo P, Mootha VK, et al Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005;102:15545–15550.
  • Shaffer A, Wright G, Yang L, et al A library of gene expression signatures to illuminate normal and pathological lymphoid biology. Immunol Rev 2006;210:67–85.
  • Gentles A, Alizadeh A, Lee S, et al A pluripotency signature predicts histologic transformation and influences survival in follicular lymphoma patients. Blood 2009;114:3158–3166.
  • Mestre-Escorihuela C, Rubio-Moscardo F, Richter JA, et al Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas. Blood 2007;109:271–280.
  • Rubio-Moscardo F, Blesa D, Mestre C, et al Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes. Blood 2005;106:3214–3222.
  • Pise-Masison CA, Radonovich M, Mahieux R, et al Transcription profile of cells infected with human T-cell leukemia virus type I compared with activated lymphocytes. Cancer Res 2002;62:3562–3571.
  • de La Fuente C, Deng L, Santiago F, Arce L, Wang L, Kashanchi F. Gene expression array of HTLV type 1-infected T cells: up-regulation of transcription factors and cell cycle genes. AIDS Res Hum Retroviruses 2000;16: 1695–1700.
  • Harhaj EW, Good L, Xiao G, Sun SC. Gene expression profiles in HTLV-I-immortalized T cells: deregulated expression of genes involved in apoptosis regulation. Oncogene 1999;18:1341–1349.
  • Pise-Masison CA, Radonovich M, Dohoney K, et al Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability. Blood 2009;113:4016–4026.
  • Inoue J, Seiki M, Taniguchi T, Tsuru S, Yoshida M. Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1. EMBO J 1986;5:2883–2888.
  • Warren AJ, Colledge WH, Carlton MB, Evans MJ, Smith AJ, Rabbitts TH. The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell 1994;78:45–57.
  • Yamada Y, Warren AJ, Dobson C, Forster A, Pannell R, Rabbitts TH. The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. Proc Natl Acad Sci USA 1998;95:3890–3895.
  • Boehm T, Foroni L, Kaneko Y, Perutz MF, Rabbitts TH. The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc Natl Acad Sci USA 1991;88:4367–4371.
  • Dong WF, Billia F, Atkins HL, Iscove NN, Minden MD. Expression of rhombotin 2 in normal and leukaemic haemopoietic cells. Br J Haematol 1996;93:280–286.
  • Creighton CJ, Bromberg-White JL, Misek DE, et al Analysis of tumor-host interactions by gene expression profiling of lung adenocarcinoma xenografts identifies genes involved in tumor formation. Mol Cancer Res 2005;3:119–129.
  • Mauri P, Scarpa A, Nascimbeni AC, et al Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers. FASEB J 2005;19:1125–1127.
  • Chung EJ, Hwang SG, Nguyen P, et al Regulation of leukemic cell adhesion, proliferation, and survival by beta-catenin. Blood 2002;100:982–990.
  • Nakayama K, Kamihira S. Survivin an important determinant for prognosis in adult T-cell leukemia: a novel biomarker in practical hemato-oncology. Leuk Lymphoma 2002;43:2249–2255.
  • Imai T, Hieshima K, Haskell C, et al Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997;91:521–530.
  • Andre F, Cabioglu N, Assi H, et al Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer. Ann Oncol 2006;17:945–951.
  • Shulby SA, Dolloff NG, Stearns ME, Meucci O, Fatatis A. CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells. Cancer Res 2004;64:4693–4698.
  • Buonamici S, Trimarchi T, Ruocco MG, et al CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia. Nature 2009;459:1000–1004.
  • Tsukasaki K, Tanosaki S, DeVos S, et al Identifying progression-associated genes in adult T-cell leukemia/lymphoma by using oligonucleotide microarrays. Int J Cancer 2004;109:875–881.
  • Hanai S, Nitta T, Shoda M, et al Integration of human T-cell leukemia virus type 1 in genes of leukemia cells of patients with adult T-cell leukemia. Cancer Sci 2004;95:306–310.
  • Ozawa T, Itoyama T, Sadamori N, et al Rapid isolation of viral integration site reveals frequent integration of HTLV-1 into expressed loci. J Hum Genet 2004;49:154–165.
  • Tsukasaki K, Krebs J, Nagai K, et al Comparative genomic hybridization analysis in adult T-cell leukemia/lymphoma: correlation with clinical course. Blood 2001;97:3875–3881.
  • Tsukasaki K. Genetic instability of adult T-cell leukemia/lymphoma by comparative genomic hybridization analysis. J Clin Immunol 2002;22:57–63.
  • Martinez-Climent JA, Alizadeh AA, Segraves R, et al Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. Blood 2003;101: 3109–3117.
  • Feng X, Ratner L. Human T-cell leukemia virus type 1 blunts signaling by interferon alpha. Virology 2008;374:210–216.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.